What was Vertex Pharmaceuticals Incorporated's revenue in 2024?

Vertex Pharmaceuticals Incorporated reported $10.7B in revenue for fiscal year 2024. This represents a +8.2% change compared to 2023. Net product revenue rose roughly 8.2% to $10.67 billion in FY2024, with Trikafta contributing $9.5 billion, or 89% of the total, and operating income reaching $4.6 billion.

What was Vertex Pharmaceuticals Incorporated's net income in 2024?

Vertex Pharmaceuticals Incorporated reported $3.8B in net income for fiscal year 2024.

How did Vertex Pharmaceuticals Incorporated's revenue change from 2023 to 2024?

Vertex Pharmaceuticals Incorporated revenue grew from $9.9B in 2023 to $10.7B in 2024, a change of 8.2%.

Was 2024 Vertex Pharmaceuticals Incorporated's best revenue year?

Yes — 2024 was Vertex Pharmaceuticals Incorporated's highest recorded revenue year at $10.7B, the peak across all 3 years of available data.

What was Vertex Pharmaceuticals Incorporated's highest ever annual revenue?

Vertex Pharmaceuticals Incorporated's highest ever annual revenue was $10.7B recorded in fiscal year 2024.

Vertex Pharmaceuticals Incorporated

BiotechnologyFounded 1989

Reviewed by Swet Parvadiya

Last reviewed: June 2026

Explore Vertex Pharmaceuticals Incorporated

Core profile pages, annual revenue records, and related research hubs for this company.

Vertex Pharmaceuticals Incorporated

BiotechnologyFounded 1989

Reviewed by Swet Parvadiya

Last reviewed: June 2026

Annual Revenue

Vertex Pharmaceuticals Incorporated Revenue in 2024

FY2024 Revenue

$10.7B

▲ 8.2% vs FY2023 ($9.9B)

Net Income: $3.8B

Source: Annual report / company filing

Vertex Pharmaceuticals Incorporated reported $10.7B in revenue for fiscal year 2024. This represents a growth of 8.2% compared to the 2023 figure of $9.9B.

Net product revenue rose roughly 8.2% to $10.67 billion in FY2024, with Trikafta contributing $9.5 billion, or 89% of the total, and operating income reaching $4.6 billion.

Revenue by Year

FY2024 FY2023 FY2022

Vertex Pharmaceuticals Incorporated Annual Revenue History

Year	Revenue	Net Income	YoY Change
FY2024	$10.7B	$3.8B	+8.2%
FY2023	$9.9B	—	+10.4%
FY2022	$8.9B	—	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

← Previous year

FY2023: $9.9B

Explore Vertex Pharmaceuticals Incorporated

Core profile pages, annual revenue records, and related research hubs for this company.